Polymarket Market
Prediction market
Track current outcome prices, market depth, volume, liquidity, and recent trades for Prediction market.
Upcoming
- Probability
- 88%
- Liquidity
- $39.13K
- Best bid
- 1%
- Best ask
- 99%
- Spread
- 98%
- Last trade
- 88%
Outcomes
Market outcomes
Live pricing
Pricing and liquidity
Current bid, ask, midpoint, spread, and market depth for this outcome.
- Best bid
- 1%
- Best ask
- 99%
- Midpoint
- 50%
- Spread
- 98%
- Last trade
- 88%
- Depth
- 38,117.26 / 1,015.17
Price history
Waiting for price history
History unavailable
Bids
| Price | Size |
|---|---|
| 1% | 26,105.01 |
| 2% | 1,160 |
| 3% | 11.39 |
| 5% | 10 |
| 8% | 350 |
| 10% | 3,600 |
| 11% | 600 |
| 20% | 1,750 |
Asks
| Price | Size |
|---|---|
| 99% | 205.01 |
| 98% | 111 |
| 97% | 13.06 |
| 94% | 83.33 |
| 88% | 602.77 |
Trades
Recent trades
Latest visible trades for this market.
- FDA approves Viatris' low-dose estrogen weekly patch?No 12% 20 shares
- FDA approves Viatris' low-dose estrogen weekly patch?Yes 87% 20 shares
- FDA approves Viatris' low-dose estrogen weekly patch?No 12% 27 shares
- FDA approves Viatris' low-dose estrogen weekly patch?No 12% 20 shares
- FDA approves Viatris' low-dose estrogen weekly patch?No 12% 20 shares
- FDA approves Viatris' low-dose estrogen weekly patch?No 12% 20 shares
- FDA approves Viatris' low-dose estrogen weekly patch?Yes 88% 28 shares
- FDA approves Viatris' low-dose estrogen weekly patch?Yes 88% 20 shares
- FDA approves Viatris' low-dose estrogen weekly patch?No 12% 41 shares
- FDA approves Viatris' low-dose estrogen weekly patch?Yes 88% 20 shares
- FDA approves Viatris' low-dose estrogen weekly patch?No 17% 20 shares
- FDA approves Viatris' low-dose estrogen weekly patch?No 10% 109 shares